Navigation Links
Tourette Syndrome Association Celebrates the House Passage of LONG-AWAITED Mental Health Parity Legislation
Date:3/6/2008

BAYSIDE, N.Y., March 6 /PRNewswire-USNewswire/ -- The national Tourette Syndrome Association, Inc. (TSA), is hailing last night's vote in the United States House of Representatives approving The Mental Health Parity Act by a vote of 268-148. Also known as The Paul Wellstone Mental Health and Addiction Equity Act (H.R. 1424), the Mental Health Parity Act would provide mental health coverage as part of health insurance packages equal to the coverage in the plans for physical illnesses. TSA is the only membership driven, non-profit organization dedicated to providing comprehensive programs of education, research and personal services to all people who have Tourette Syndrome (TS) and their families.

"For close to two decades, TSA and our members have been vigorously advocating for this legislation which would provide financial and health coverage relief to all Americans, including those with Tourette Syndrome," said Judit Ungar, President, TSA. "Passage of this bill is a huge victory. For the first time in the history of Mental Health Parity legislation, both the House and Senate have passed a bill aimed at ensuring that health insurance plans offer fair coverage for all illness, be it physical or mental."

Mental Health Parity is critical with long-standing importance to TSA and millions more. Parity fights discrimination, but more importantly it provides financial relief to those who pay an exorbitant amount of money out of pocket for their mental health coverage. Parity will cushion the enormous medical costs and provide proper medical care for the onset and treatment of neurobiological disorders such as TS.

TSA members were instrumental in the passage of this historical victory, by answering TSA's calls to action, contacting their local Representatives and urging them to vote for this crucial legislation.

"We are closer than ever to finally having comprehensive Parity legislation to benefit individuals with TS and all Americ
'/>"/>

SOURCE Tourette Syndrome Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. University Hospitals Case Medical Center finds new treatment holds promise for Tourette syndrome
2. James Marsden and Ashley & Jeffrey McDermott to Receive Honors at the Tourette Syndrome Association 2008 Champion of Children Awards Dinner
3. Diabetes appears to increase risk of death for patients with acute coronary syndromes
4. Eye-staining technique offers early detection for dry eye syndrome
5. Pollen, Fruits, Veggies Help Trigger Oral Allergy Syndrome
6. Treating depression may improve recovery of heart rate variability following coronary syndromes
7. Stem cell research produces a key discovery for Fragile X Syndrome
8. Metabolic syndrome heightens risk for development of uric-acid kidney stones
9. Stomach Virus a Culprit in Chronic Fatigue Syndrome
10. Chronic fatigue syndrome linked to stomach virus
11. Toward a faster prenatal test for Down syndrome

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ising incidence of obesity could counter recent in... 2 (HealthDay News) -- The overall health of the U...cades, largely because people have quit smoking in...t soon be wiped out if the rising obesity rates am...rent trends in both smoking and obesity continue u...
(Date:12/2/2009)...hes now available, many more to come, NIH director... News) -- Thirteen stem cell lines have been adde...-funded research, and many more such lines will so...ced Wednesday. , These are the first additional...unded by the U.S. National Institutes of Health (N...
(Date:12/2/2009)...WHITE PLAINS, N.Y., Dec. 2 /PRNewswire-USNewswire/... their findings in blood cancer research at the an...ce in New Orleans December 4-8, 2009. ,, Throu...oma Society (LLS) experts, including Chief Medical...esident of Patient Services Hildy Dillon, and Vice...
(Date:12/2/2009)...PHILADELPHIA, Dec. 2 Independence ...nefits contract with Lincoln Financial Group. IBC ...or approximately 10,000 Lincoln Financial Group em... nation. The Lincoln plan offerings will include t...s. ,, "I know I speak for all of us at Independ...
(Date:12/2/2009)...Joseph Balboni loves sports. An avid tennis player...old insurance agent became increasingly frustrated...us, a degenerative eye disorder. Unable to return ... he faced the prospect of a corneal transplant to ... years ago, Balboni discovered an alternative trea...
Breaking Medicine News(10 mins):Health News:Health Gains From Lowered Smoking Rates in Jeopardy 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 3Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 2Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 3Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 3Health News:Brandeis studies evaluate visionary approach to improving eyesight 2
... Infections during the first year of life are a ma...s of arthritis later in life, according to new res...he Annual Congress of the European League Against ...irst birthday had an increased likelihood of devel...
...he issue of selling kidneys. , A regulated system...tion to the growing shortage of kidneys for transp...ry at the University of Minnesota. , In many are...is the annual death rate for suitable transplant c...
...pedics, Inc., a,leader in orthopedic extremity imp...ecutives, William F. Warrender, Jr., John F. Walte...s. Their extensive background and,experience will ...les. He brings more than 25 years of sales, market...
...Certain single nucleotide polymorphisms (SNPs) wit...region are shown to be associated with juvenile id... of two independent cohorts presented today at EUL... genetic code), rs2104286, rs41295061 and rs115946...
... WASHINGTON, June 13 A team of professionals,fro...to Germany on Saturday,to work with the US Army,s ...ng their current rehabilitation practices. They wi...tation,services. The ERMC operates 15 ambulatory c...
... try to resolve remaining issues, TORONTO, June 1...pany,PreMD Inc. (TSX: PMD; Amex: PME) today announ... the U.S. Food and Drug Administration (FDA) in an...next 60 days PreMD and the FDA will work together ...
Other Medicine News:Health News:Early life infections increase the risk of rheumatoid arthritis and juvenile idiopathic arthritis 2Health News:What's wrong with selling kidneys? 2Health News:Three Industry Veterans Join Ascension Orthopedics 2Health News:Three Industry Veterans Join Ascension Orthopedics 3Health News:Specific mutations in the IL2RA gene associated with juvenile idiopathic arthritis 2Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 2Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 3Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 4Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 5Health News:PreMD Reports Further Positive Meetings with the FDA 2
(Date:12/2/2009)..., , EAST HANOVER, N.J., Dec. 2 /PRNe... including a late-breaking presentation on Tasigna...ronic myeloid leukemia, demonstrate the strength o...the care of patients. ,, The new data, at the ...eeting and Exposition, highlight the company,s cur...
(Date:12/1/2009)..., , TEMECULA, Calif., Dec. 1 /PRNewswire-Fir...Bulletin Board: PSTX) announced today that it has ...f Chief Financial Officer, Treasurer and Corporate...ting CFO since 2008. Prior to joining Patient Saf...t Finance, Chief Financial Officer, Treasurer and ...
(Date:12/1/2009)..., , REDONDO BEACH, Calif., Dec. 1 /PRNewswire...ounces their Elective Single Embryo Transfer (eSET...entive for patients with good embryo quality and a...he chance of twins by transferring a single embryo... technology today is reducing the number of multip...
Breaking Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2Reproductive Partners Announces Elective Single Embryo Transfer (eSET) Encouragement Program 2GSK Advisory 3A Warehouse Theft 55192 1GSK Advisory 3A Warehouse Theft 55192 2American Lung Association in Minnesota 3A Motorists Can Get 85 Cents a Gallon E85 Fuel in Woodbury Minn 55189 1AMERIGROUP Corporation to Host Investor Day 55187 1
...ty of Hematology (ASH) and the American Society of... joint guideline on the use of,erythropoiesis-stim...late,the bone marrow to produce more red blood cel...oal of these guidelines is to inform clinicians wi...studies regarding the risks and,benefits of ESAs i...
...pplications for RNAi, WALTHAM, Mass., Oct. 22 Th...ld leader in serving science, has,collaborated wit...echnology,platform that expands applications for R...sciences research, including neuroscience, immunol...d Thermo Scientific Dharmacon(R),SMARTvector(TM) s...
Other Medicine Technology:ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients 2ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients 3Thermo Fisher Scientific Advances Gene-Silencing Technology for Life Sciences Research 2Thermo Fisher Scientific Advances Gene-Silencing Technology for Life Sciences Research 3
Shepard Bipolar Forceps Straight
Shepard Bipolar Forceps Angled
McCullough Bipolar Forceps
Dean Tonsil Knife
Medicine Products: